Violation Tracker Individual Record
Company:
Inspire Pharmaceuticals
Current Parent Company:
Merck
Penalty:
$6,000,000
Year:
2015
Date:
June 18, 2015
Offense Group:
healthcare-related offenses
Primary Offense:
off-label or unapproved promotion of medical products
Violation Description:
Inspire Pharmaceuticals agreed to pay $6 million to settle multistate allegations that it violated state and federal False Claims Act laws by illegally marketing the drug Azasite for off-label uses not approved by the U.S. Food and Drug Administration. Also involved in the settlement was the federal government, which issued its own announcement; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-inspire-ph...
Level of Government:
state
Action Type:
agency action
Agency:
Multistate Attorneys General Case
Civil or Criminal Case:
civil
HQ Country of Parent:
USA
HQ State of Parent:
New Jersey
Ownership Structure of Parent:
publicly traded
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
